CATALYST BIOSCIENCES
Catalyst Biosciences is a drug discovery and development company. It is creating novel catalytic biopharmaceutical products based on engineered human proteases. It is developing proteases for the treatment of a broad range of diseases with a strong focus on hemostasis and inflammation. It is focused on protease therapeutics to address unmet medical needs in disorders of the coagulation systems.
CATALYST BIOSCIENCES
Industry:
Biotechnology Health Care Life Science Medical Medical Device Pharmaceutical Therapeutics
Founded:
1997-01-01
Address:
South San Francisco, California, United States
Country:
United States
Website Url:
http://www.catalystbiosciences.com
Total Employee:
11+
Status:
Active
Contact:
+1 650 871 0761
Total Funding:
301.31 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API LetsEncrypt WordPress Content Delivery Network Wordpress Plugins Nginx IPv6
Similar Organizations
Arbutus Biopharma
Arbutus Biopharma Corporation is a publicly-traded biopharmaceutical company.
Cantel Medical
Cantel Medical is a provider of infection prevention products and services for caregivers, patients, and other healthcare providers.
Vero Biotech
Vero Biotech is a biopharmaceutical company that commercializes inhaled nitric oxide delivery systems for healthcare providers.
Getinge
Getinge identifies customer issues and promotes clinical and economic benefits and follow and support the customer decision process.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Biologics Consulting
Biologics Consulting is a product development consulting firm for biologics, pharmaceuticals, and medical devices.
Thermogenesis
Thermogenesis, a health care company, focuses in development of automated technologies for cell-based therapeutics and bioprocessing.
Asensus Surgical
Asensus Surgical is a medical device company that digitizes the interface between the surgeon and the patient.
Current Advisors List
Board_member
Board_member
Board_member
Board_member
Board_member
Board_member
Board_member
Board_member
Current Employees Featured
Clinton Musil Chief Financial Officer @ Catalyst Biosciences
Chief Financial Officer
William Dawson Chief Financial Officer @ Catalyst Biosciences
Chief Financial Officer
Charles S. Craik Co-Founder and Chairman of Scientific Advisory Board @ Catalyst Biosciences
Co-Founder and Chairman of Scientific Advisory Board
Jessica Beaver Senior Director, Regulatory Affairs and Quality Compliance @ Catalyst Biosciences
Senior Director, Regulatory Affairs and Quality Compliance
Hodges Mauri Vice President, Finance and Administration, Chief Financial Officer and Treasurer @ Catalyst Biosciences
Vice President, Finance and Administration, Chief Financial Officer and Treasurer
Nassim Usman President & CEO, Member Board of Directors @ Catalyst Biosciences
President & CEO, Member Board of Directors
2006-01-01
Mike Smith Chief Financial & Business Advisor @ Catalyst Biosciences
Chief Financial & Business Advisor
2012-06-01
Merouane Bencherif Senior Vice President, Preclinical Research @ Catalyst Biosciences
Senior Vice President, Preclinical Research
Founder
Stock Details
Investors List
Essex Woodlands Healthcare Partners
Essex Woodlands Healthcare Partners investment in Post-IPO Equity - Catalyst Biosciences
HealthCare Ventures
HealthCare Ventures investment in Post-IPO Equity - Catalyst Biosciences
Morgenthaler Ventures
Morgenthaler Ventures investment in Post-IPO Equity - Catalyst Biosciences
Johnson & Johnson Development Corporation
Johnson & Johnson Development Corporation investment in Post-IPO Equity - Catalyst Biosciences
Burrill & Company
Burrill & Company investment in Post-IPO Equity - Catalyst Biosciences
Novartis Venture Fund
Novartis Venture Fund investment in Post-IPO Equity - Catalyst Biosciences
Essex Woodlands Healthcare Partners
Essex Woodlands Healthcare Partners investment in Post-IPO Equity - Catalyst Biosciences
Burrill & Company
Burrill & Company investment in Post-IPO Equity - Catalyst Biosciences
Sofinnova Investments
Sofinnova Investments investment in Post-IPO Equity - Catalyst Biosciences
Morgenthaler Ventures
Morgenthaler Ventures investment in Post-IPO Equity - Catalyst Biosciences
Key Employee Changes
| Date | New article |
|---|---|
| 2021-10-13 | Catalyst Biosciences Announces Chief Financial Officer Transition |
Official Site Inspections
http://www.catalystbiosciences.com Semrush global rank: 2.44 M Semrush visits lastest month: 7.37 K
- Host name: ewhserver1302.edgewebhosting.net
- IP address: 69.63.140.80
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
Catalystbiosciences.com lookup results from whois.networksolutions.com server:
- Domain created: 28th-Jan-2004
- Domain updated: 29th-Nov-2024
- Domain expires: 28th-Jan-2027 1 Year, 225 Days left
- Website age: 21 Years, 139 Days
- Registrar Domain ID: 110731212_DOMAIN_COM-VRSN
- Registrar Url: http://networksolutions.com
- Registrar WHOIS Server: whois.networksolutions.com
- Registrar Abuse Contact Email: domain.operations@web.com
- Registrar Abuse Contact Phone: +1.8777228662
- Name server:
- NS67.WORLDNIC.COM
- NS68.WORLDNIC.COM
More informations about "Catalyst Biosciences"
Catalyst Biosciences - Crunchbase Company Profile & Funding
Catalyst Biosciences is a research and clinical development biopharmaceutical company. They focus on addressing unmet medical needs in rare disorders of the complement and …See details»
Catalyst Biosciences Completes First Steps in Reverse Merger Plan
Dec 27, 2022 Leadership & Organization Effective with the closing of the F351 acquisition, the Catalyst Board will consist of three legacy Catalyst directors (Augustine Lawlor, Nassim …See details»
Catalyst Biosciences Company Profile | Management and
Www.catalystbiosciences.com . Catalyst Biosciences Profile and History. Catalyst is a research and clinical development biopharmaceutical company focused on addressing unmet medical …See details»
Catalyst Biosciences - LinkedIn
Catalyst Biosciences | 7,104 followers on LinkedIn. Catalyst is a research and clinical development biopharmaceutical company focused on addressing unmet medical needs in rare …See details»
Catalyst Biosciences - Overview, News & Similar companies
May 14, 2024 View Catalyst Biosciences (www.catalystbiosciences.com) location in California, United States , revenue, industry and description. ... Nassim Usman, President & Chief …See details»
Catalyst Biosciences - Company Profile - Tracxn
Jan 31, 2025 Catalyst is a clinical-stage biopharmaceutical company leveraging exceptional science to discover and develop essential medicines across range of diseases. scientific …See details»
Catalyst Biosciences, Inc. - Drug pipelines, Patents, Clinical trials ...
Mar 6, 2025 Explore Catalyst Biosciences, Inc. with its drug pipeline, therapeutic area, technology platform, 33 clinical trials, 41 news, and 68 literature, Disease Domain:Nervous …See details»
Catalyst Biosciences - Golden
611 Gateway Blvd Ste 710 South San Francisco , CA, 94080-7029 United States611 Gateway Blvd Ste 710 South San Francisco , CA, 94080-7029 United States 0See details»
Catalyst Biosciences - VentureRadar
"Catalyst Biosciences is a biopharmaceutical company with expertise in protease engineering. Prior to ceasing research and development activities in March 2022, the Company had several …See details»
Catalyst Biosciences - VentureRadar
Catalyst Biosciences is a biopharmaceutical company with expertise in protease engineering. Prior to ceasing research and development activities in... ... Find out ...See details»
Catalyst Biosciences Company Profile -Sales, Contacts, …
Catalyst Biosciences, Inc. (trade name CATALYST) is in the Pharmaceutical Preparations business. View competitors, revenue, employees, website and phone number.See details»
Catalyst Biosciences - Craft
Oct 30, 2023 Catalyst Biosciences is a drug R&D company creating catalytic biopharmaceutical products based on engineered human proteases. The Company uses a scientific approach …See details»
Company Catalyst Biosciences - MarketScreener.com
4 days ago Catalyst Biosciences, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of Hydronidone for the treatment of nonalcoholic …See details»
Catalyst Biosciences Company Overview, Contact Details
Jan 27, 2021 John@catalystbiosciences.com: 20%. See more formats. Frequently Asked Questions Where is Catalyst Biosciences 's headquarters located? Catalyst Biosciences 's …See details»
Catalyst Biosciences Announces Global License and Collaboration ...
For more information, please visit www.catalystbiosciences.com. Forward-Looking Statements This press release contains forward-looking statements that involve substantial risks and …See details»
Catalyst Biosciences Completes First Steps in Reverse Merger Plan
Dec 27, 2022 Acquires F351, a Phase 3 Drug to Treat Fibrosis Will Acquire Controlling Interest in Continent, a China-Based Commercial Pharma Company, from the GNI Group in …See details»
Catalyst Biosciences Presents Positive Final Data from its Phase 2b ...
Jun 15, 2020 SOUTH SAN FRANCISCO, Calif., June 15, 2020 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ: CBIO), today announced final efficacy and safety data …See details»
Catalyst Biosciences Completes First Steps in Reverse
Dec 27, 2022 Leadership & Organization Effective with the closing of the F351 acquisition, the Catalyst Board will consist of three legacy Catalyst directors (Augustine Lawlor, Nassim Usman.See details»
Catalyst Biosciences Announces Change in Corporate Strategy
Nov 12, 2021 Three Months Ended September 30, Nine Months Ended September 30, 2021 2020 2021 2020 Revenue: LicenseSee details»
Establishing Canada’s first large-scale bioinnovation centre
4 days ago The Neptune BioInnovation Centre (NBC), a 51,000 sq ft facility on a 12.3 acre lot in Dartmouth, will offer leasable wet and dry lab space, warehouse and office spaces, and …See details»